HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seyed Mohammad Taghdisi Selected Research

5TR1 aptamer

9/2020Combination therapy using Smac peptide and doxorubicin-encapsulated MUC 1-targeted polymeric nanoparticles to sensitize cancer cells to chemotherapy: An in vitro and in vivo study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seyed Mohammad Taghdisi Research Topics

Disease

5Neoplasms (Cancer)
03/2024 - 09/2020
2Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 07/2022
1Melanoma (Melanoma, Malignant)
03/2024
1Breast Neoplasms (Breast Cancer)
06/2023
1Colonic Neoplasms (Colon Cancer)
07/2022

Drug/Important Bio-Agent (IBA)

2APTIBA
03/2024 - 09/2020
2GoldIBA
03/2024 - 06/2023
2AGRO 100IBA
03/2024 - 07/2022
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2024 - 09/2020
1Methotrexate (Mexate)FDA LinkGeneric
03/2024
1bismuth oxide (bismuth trioxide)IBA
03/2024
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2024
1glyceryl methacrylateIBA
07/2022
1NucleolinIBA
07/2022
1ManganeseIBA
07/2022
1Proteins (Proteins, Gene)FDA Link
09/2020
1SMAC peptideIBA
09/2020
15TR1 aptamerIBA
09/2020

Therapy/Procedure

3Therapeutics
03/2024 - 09/2020
3Precision Medicine
03/2024 - 07/2022
2Drug Therapy (Chemotherapy)
03/2024 - 09/2020
1Intravenous Injections
06/2023
1Intravenous Administration
07/2022